CGM = continuous glucose monitoring.
* Based on a survey of Canadian endocrinologists (n=41). 
† Based on commercially available CGM systems as of May 1, 2025. 
‡ Audible and visual notification of predictive alert at 3.1 mmol/L within 20 minutes.  

1 dQ&A, Dexcom Canadian Endos Report Wave 1 2024. 
2 Dexcom, Data on file, 2025. 
3 Beck RW, et al. JAMA. 2017;317(4):371-378. 
4 Beck RW, et al. Ann Intern Med. 2017;167(6) 365-374. 
5 Martens T, et al. JAMA. 2021;325(22):2262-2272. 
6 Leffel LM, et al. JAMA. 2020;323(23):2388-2396. 
7 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-147. 
8 Dexcom G7 User Guide. 

Dexcom and Dexcom G7 are registered trademarks of Dexcom, Inc. in the U.S. and may be registered in other countries.© 2025 Dexcom Canada, Co. All rights reserved. MAT-8255 Vl.0